Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-18

Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metabolic combination treatments for cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Health Clinics Limited | Conditions: Cancer, Overall Survival | Phase 3 | Status: WITHDRAWN